본문 바로가기
KERD
논문KCI 등재

Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis

2

조회

0

다운로드

2

인용

0

참고문헌

주제분류생화학

초록

Low back pain (LBP) is a major musculoskeletal disorder and the socioeconomic problem with a high prevalence that mainly involves intervertebral disc (IVD) degeneration, characterized by progressive nucleus pulposus (NP) cell death and the development of an inflammatory microenvironment in NP tissue. Excessively accumulated cytosolic DNA acts as a damage-associated molecular pattern (DAMP) that is monitored by the cGAS-STING axis to trigger the immune response in many degenerative diseases. NLRP3 inflammasome-dependent pyroptosis is a type of inflammatory programmed death that promotes a chronic inflammatory response and tissue degeneration. However, the relationship between the cGAS-STING axis and NLRP3 inflammasome-induced pyroptosis in the pathogenesis of IVD degeneration remains unclear. Here, we used magnetic resonance imaging (MRI) and histopathology to demonstrate that cGAS, STING, and NLRP3 are associated with the degree of IVD degeneration. Oxidative stress induced cGAS-STING axis activation and NLRP3 inflammasome-mediated pyroptosis in a STING-dependent manner in human NP cells. Interestingly, the canonical morphological and functional characteristics of mitochondrial permeability transition pore (mPTP) opening with the cytosolic escape of mitochondrial DNA (mtDNA) were observed in human NP cells under oxidative stress. Furthermore, the administration of a specific pharmacological inhibitor of mPTP and self-mtDNA cytosolic leakage effectively reduced NLRP3 inflammasome-mediated pyroptotic NP cell death and microenvironmental inflammation in vitro and degenerative progression in a rat disc needle puncture model. Collectively, these data highlight the critical roles of the cGAS-STING-NLRP3 axis and pyroptosis in the progression of IVD degeneration and provide promising therapeutic approaches for discogenic LBP.

Abstract

Low back pain (LBP) is a major musculoskeletal disorder and the socioeconomic problem with a high prevalence that mainly involves intervertebral disc (IVD) degeneration, characterized by progressive nucleus pulposus (NP) cell death and the development of an inflammatory microenvironment in NP tissue. Excessively accumulated cytosolic DNA acts as a damage-associated molecular pattern (DAMP) that is monitored by the cGAS-STING axis to trigger the immune response in many degenerative diseases. NLRP3 inflammasome-dependent pyroptosis is a type of inflammatory programmed death that promotes a chronic inflammatory response and tissue degeneration. However, the relationship between the cGAS-STING axis and NLRP3 inflammasome-induced pyroptosis in the pathogenesis of IVD degeneration remains unclear. Here, we used magnetic resonance imaging (MRI) and histopathology to demonstrate that cGAS, STING, and NLRP3 are associated with the degree of IVD degeneration. Oxidative stress induced cGAS-STING axis activation and NLRP3 inflammasome-mediated pyroptosis in a STING-dependent manner in human NP cells. Interestingly, the canonical morphological and functional characteristics of mitochondrial permeability transition pore (mPTP) opening with the cytosolic escape of mitochondrial DNA (mtDNA) were observed in human NP cells under oxidative stress. Furthermore, the administration of a specific pharmacological inhibitor of mPTP and self-mtDNA cytosolic leakage effectively reduced NLRP3 inflammasome-mediated pyroptotic NP cell death and microenvironmental inflammation in vitro and degenerative progression in a rat disc needle puncture model. Collectively, these data highlight the critical roles of the cGAS-STING-NLRP3 axis and pyroptosis in the progression of IVD degeneration and provide promising therapeutic approaches for discogenic LBP.

참고문헌 (60)

  1. Cieza, A., "Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019 : a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.2006~2017 (2021)
  2. "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.1204~1222 (2020)
  3. Martin, B. I., "Expenditures and health status among adults with back and neck problems", JAMA, 299, pp.656~664 (2008)
  4. Hartvigsen, J., "What low back pain is and why we need to pay attention", Lancet, 391, pp.2356~2367 (2018)
  5. Frapin, L., "Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors", Adv. Drug Deliv. Rev, 149-150, pp.49~71 (2019)
  6. "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016", Lancet, 390, pp.1211~1259 (2017)
  7. Binch, A. L. A., "Cell-based strategies for IVD repair: clinical progress and translational obstacles", Nat. Rev. Rheumatol, 17, pp.158~175 (2021)
  8. Lyu, F. J., "Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions", Bone Res, 9, pp.7~ (2021)
  9. Vadalà, G., "Intervertebral disc regeneration:from the degenerative cascade to molecular therapy and tissue engineering", J. Tissue Eng. Regen. M, 9, pp.679~690 (2015)
  10. Lyu, F. J., "IVD progenitor cells: a new horizon for understanding disc homeostasis and repair", Nat. Rev. Rheumatol, 15, pp.102~112 (2019)
  11. Lan, T., "New insights into the interplay between miRNAs and autophagy in the aging of intervertebral discs", Ageing Res. Rev, 65, pp.101227~ (2021)
  12. Ji, M. L., "Preclinical development of a microRNA-based therapy for intervertebral disc degeneration", Nat. Commun, 9, pp.505~ (2018)
  13. Che, H., "p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle", eLife, 9, pp.e52570~ (2020)
  14. Huang Bao, "The RCAN1.4-calcineurin", NFAT signaling pathway is essential for hypoxic adaption of intervertebral discs, 2020, pp.52, 1~11[DOI]
  15. Smith, L. J., "Degeneration and regeneration of the intervertebral disc : lessons from development", Dis. Model Mech, 4, pp.31~41 (2011)
  16. Hopfner, K. P., "Molecular mechanisms and cellular functions of cGAS-STING signalling", Nat. Rev. Mol. Cell Biol, 21, pp.501~521 (2020)
  17. Motwani, M., "DNA sensing by the cGAS-STING pathway in health and disease", Nat. Rev. Genet, 20, pp.657~674 (2019)
  18. Yu, C. H., "TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS", STING in ALS, 2020, pp.183, 636~649.e618
  19. Kerur, N., "cGAS drives noncanonical-inflammasome activation in age-related macular degeneration", Nat. Med, 24, pp.50~61 (2018)
  20. Decout, A., "The cGAS-STING pathway as a therapeutic target in inflammatory diseases", Nat. Rev. Immunol, 21, pp.548~569 (2021)
  21. Moriyama, M., "Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses", Nat. Commun, 10, pp.4624~ (2019)
  22. Bi, X., "Mitochondrial damage-induced innate immune activation in vascular smooth muscle cells promotes chronic kidney disease-associated plaque vulnerability", Adv. Sci, 8, pp.2002738~ (2021)
  23. Chung, K. W., "Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis", Cell Metab, 30, pp.784~799.e785 (2019)
  24. Huang, L. S., "mtDNA activates cGAS signaling and suppresses the YAPmediated endothelial cell proliferation program to promote inflammatory injury", Immunity, 52, pp.475~486.e475 (2020)
  25. Swanson, K. V., "The NLRP3 inflammasome : molecular activation and regulation to therapeutics", Nat. Rev. Immunol, 19, pp.477~489 (2019)
  26. He, Y., "Mechanism and regulation of NLRP3 inflammasome activation", Trends Biochem. Sci, 41, pp.1012~1021 (2016)
  27. Shi, J., "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death", Nature, 526, pp.660~665 (2015)
  28. Ding, J., "Pore-forming activity and structural autoinhibition of the gasdermin family", Nature, 535, pp.111~116 (2016)
  29. Bedoui, S., "Emerging connectivity of programmed cell death pathways and its physiological implications", Nat. Rev. Mol. Cell Biol, 21, pp.678~695 (2020)
  30. Tang, D., "The molecular machinery of regulated cell death", Cell Res, 29, pp.347~364 (2019)
  31. Pfirrmann, C. W., "Magnetic resonance classification of lumbar intervertebral disc degeneration", Spine (Philos. Pa 1976), 26, pp.1873~1878 (1976)
  32. Chen, F., "Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β", NF-κB-NLRP3 inflammasome positive feedback loop, 2020, pp.8, 10~
  33. Song, Y., "Sirtuin 3-dependent mitochondrial redox homeostasis protects against AGEs-induced intervertebral disc degeneration", Redox Biol, 19, pp.339~353 (2018)
  34. Tian, Y., "Epigallocatechin-3-gallate protects H(2)O(2)-induced nucleus pulposus cell apoptosis and inflammation by inhibiting cGAS", Sting, Drug Des. Dev. Ther, pp.2020, 14[DOI]
  35. Luo, L., "Cartilage endplate stem cells inhibit intervertebral disc degeneration by releasing exosomes to nucleus pulposus cells to activate Akt", autophagy, 2021, pp.39, 467~481
  36. Jianle Wang, "Small molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration", Experimental and Molecular Medicine, 50, pp.1~14 (2018), 생화학분자생물학회
  37. Cloughesy, T. F., "Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma", Nat. Med, 25, pp.477~486 (2019)
  38. Wagner, J., "A single-cell atlas of the tumor and immune ecosystem of human breast cancer", Cell, 177, pp.1330~1345.e1318 (2019)
  39. Shimada, K., "Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis", Immunity, 36, pp.401~414 (2012)
  40. Cheng, X., "Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein", Ann. Rheum. Dis, 77, pp.770~779 (2018)
  41. Chen, D., "Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo", Cell Death Dis, 7, pp.e2441~ (2016)
  42. Mao, H. J., "The effect of injection volume on disc degeneration in a rat tail model", Spine (Philos. Pa 1976), 36, pp.e1062~e1069 (1976)
  43. Rutges, J. P., "A validated new histological classification for intervertebral disc degeneration", Osteoarthr. Cartil, 21, pp.2039~2047 (2013)
  44. Boos, N., "Classification of age-related changes in lumbar intervertebral discs:2002 Volvo Award in basic science", Spine (Philos. Pa 1976), 27, pp.2631~2644 (1976)
  45. Ergun, S. L., "STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition", Cell, 178, pp.290~301.e210 (2019)
  46. Chao-Yang, G., "Roles of NLRP3 inflammasome in intervertebral disc degeneration", Osteoarthr. Cartil, 6, pp.793~801 (2021)
  47. Wu, D., "Cell death mediated by the pyroptosis pathway with the aid of nanotechnology : prospects for cancer therapy", Angew. Chem. Int. Ed. Engl, 60, pp.8018~8034 (2021)
  48. Ning, L., "Cytosolic DNA-STING-NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide", Clin. Transl. Med, 10, pp.e228~ (2020)
  49. Gaidt, M. M., "The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3", Cell, 171, pp.1110~1124.e1118 (2017)
  50. Haag, S. M., "Targeting STING with covalent small-molecule inhibitors", Nature, 559, pp.269~273 (2018)
  51. Liang, H. L., "SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery", Free Radic. Biol. Med, 49, pp.1550~1560 (2010)
  52. Wu, C. C., "Regulation of the intrinsic apoptosis pathway by reactive oxygen species", Antioxid. Redox Sign, 19, pp.546~558 (2013)
  53. Risbud, M. V., "Role of cytokines in intervertebral disc degeneration : pain and disc content", Nat. Rev. Rheumatol, 10, pp.44~56 (2014)
  54. Foster, N. E., "Prevention and treatment of low back pain: evidence, challenges, and promising directions", Lancet, 391, pp.2368~2383 (2018)
  55. Kwong, J. Q., "Physiological and pathological roles of the mitochondrial permeability transition pore in the heart", Cell Metab, 21, pp.206~214 (2015)
  56. Shanmughapriya, S., "SPG7 is an essential and conserved component of the mitochondrial permeability transition pore", Mol. Cell, 60, pp.47~62 (2015)
  57. Webster, S. J., "Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infection", PLoS Pathog, 13, pp.e1006383~ (2017)
  58. Fidler, T. P., "The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis", Nature, 592, pp.296~301 (2021)
  59. Murthy, A. M. V., "Crosstalk between cGAS-STING signaling and cell death", Cell Death Differ, 27, pp.2989~3003 (2020)
  60. Paludan, S. R., "DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer", Nat. Rev. Immunol, 19, pp.141~153 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (191건)